US Patent 11161852 Inhibitors of NEK7 kinase
Patent 11161852 was granted and assigned to Halia Therapeutics, Inc. on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
Compounds having activity as inhibitors of NEK7 are provided. The compounds have Structure (I):
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111618520
Date of Patent
November 2, 2021
0Patent Application Number
202105070
Date Filed
May 7, 2021
0Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111618520
Date of Patent
November 2, 2021
0Patent Application Number
202105070
Date Filed
May 7, 2021
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11161852 Inhibitors of NEK7 kinase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11161852
Date of patent
November 2, 2021
Patent application number
20210507
Date Filed
May 7, 2021
Find more entities like US Patent 11161852 Inhibitors of NEK7 kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
